MRK

Pfizer Inc. PFE 2.79% expects demand for its Covid-19 antiviral drug to increase as governments return to replenish their supplies and…

The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a…

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under…

Researchers and U.S. health regulators worry Covid-19 will figure out a way to evade important new pills, prompting efforts to look for signs of such resistance and find combinations to…

The past two years of remote work reveal that for chief information officers, architects of enterprisewide technology transformation, few tools are as important as a decent computer and…

The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but they carry safety warnings and limitations that could complicate treatment…

U.S. regulators cleared use of a Covid-19 pill from Merck MRK -0.32% & Co. and partner Ridgeback Biotherapeutics LP, the latest…

U.S. health regulators cleared use of a Covid-19 pill from Pfizer Inc., the first drug that newly infected patients can now take at home to stay out of the…

The bright orange capsule that could transform Covid-19 treatment wasn’t on the radar in January 2020 when the pandemic was unfolding.The drug had never been tested in humans. Lab…

Weeks after Merck MRK -0.33% & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing…